GB201313909D0 - Powder formulation - Google Patents

Powder formulation

Info

Publication number
GB201313909D0
GB201313909D0 GBGB1313909.2A GB201313909A GB201313909D0 GB 201313909 D0 GB201313909 D0 GB 201313909D0 GB 201313909 A GB201313909 A GB 201313909A GB 201313909 D0 GB201313909 D0 GB 201313909D0
Authority
GB
United Kingdom
Prior art keywords
powder formulation
formulation
powder
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1313909.2A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Profibrix BV
Original Assignee
Profibrix BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Profibrix BV filed Critical Profibrix BV
Priority to GBGB1313909.2A priority Critical patent/GB201313909D0/en
Publication of GB201313909D0 publication Critical patent/GB201313909D0/en
Priority to EA201591657A priority patent/EA201591657A1/en
Priority to PCT/EP2014/054477 priority patent/WO2014135689A2/en
Priority to AU2014224594A priority patent/AU2014224594B2/en
Priority to MX2015011623A priority patent/MX2015011623A/en
Priority to US14/773,212 priority patent/US20160015792A1/en
Priority to EP14709244.9A priority patent/EP2964252A2/en
Priority to JP2015560712A priority patent/JP2016510059A/en
Priority to CN201480012686.4A priority patent/CN105188740A/en
Priority to BR112015017463A priority patent/BR112015017463A8/en
Priority to CA2898922A priority patent/CA2898922A1/en
Priority to IL240902A priority patent/IL240902A0/en
Priority to US16/408,678 priority patent/US20190269764A1/en
Ceased legal-status Critical Current

Links

GBGB1313909.2A 2013-02-08 2013-08-02 Powder formulation Ceased GB201313909D0 (en)

Priority Applications (13)

Application Number Priority Date Filing Date Title
GBGB1313909.2A GB201313909D0 (en) 2013-08-02 2013-08-02 Powder formulation
CA2898922A CA2898922A1 (en) 2013-03-07 2014-03-07 Powder formulation
EP14709244.9A EP2964252A2 (en) 2013-03-07 2014-03-07 Powder formulation comprising thrombin and fibrinogen
PCT/EP2014/054477 WO2014135689A2 (en) 2013-03-07 2014-03-07 Powder formulation
AU2014224594A AU2014224594B2 (en) 2013-03-07 2014-03-07 Powder formulation comprising thrombin and fibrinogen
MX2015011623A MX2015011623A (en) 2013-03-07 2014-03-07 Powder formulation comprising thrombin and fibrinogen.
US14/773,212 US20160015792A1 (en) 2013-03-07 2014-03-07 Powder formulation comprising thrombin and fibrinogen
EA201591657A EA201591657A1 (en) 2013-03-07 2014-03-07 POWDER COMPOSITION
JP2015560712A JP2016510059A (en) 2013-03-07 2014-03-07 Powder formulation
CN201480012686.4A CN105188740A (en) 2013-03-07 2014-03-07 Powder formulation comprising thrombin and fibrinogen
BR112015017463A BR112015017463A8 (en) 2013-03-07 2014-03-07 POWDER FORMULATION
IL240902A IL240902A0 (en) 2013-03-07 2015-08-27 Powder formulation comprising thrombin and fibrinogen
US16/408,678 US20190269764A1 (en) 2013-02-08 2019-05-10 Powder formulation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1313909.2A GB201313909D0 (en) 2013-08-02 2013-08-02 Powder formulation

Publications (1)

Publication Number Publication Date
GB201313909D0 true GB201313909D0 (en) 2013-09-18

Family

ID=49224104

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1313909.2A Ceased GB201313909D0 (en) 2013-02-08 2013-08-02 Powder formulation

Country Status (1)

Country Link
GB (1) GB201313909D0 (en)

Similar Documents

Publication Publication Date Title
IL288961A (en) Pharmaceutical compositions
ZA201602461B (en) Powder coating composition
EP3065716C0 (en) Formulations
PL2943181T3 (en) Pharmaceutical compositions
EP2970924A4 (en) Phytase formulation
GB201319792D0 (en) Formulations
HK1214951A1 (en) Ophthalimic formulations
GB201320432D0 (en) Novel formulation
GB201322948D0 (en) Improved formulation
HRP20171888T1 (en) Pharmaceutical compositions
GB2517232B (en) Formulation
GB201317718D0 (en) Novel formulation
GB2518724B (en) Edible formulation
GB201304699D0 (en) Pharmaceutical compositions
GB201313909D0 (en) Powder formulation
HK1209981A1 (en) Formulation
GB201304145D0 (en) Powder formulation
GB201304146D0 (en) Powder formulation
IL244316A0 (en) Novel drug formulation
GB201303337D0 (en) Powder
GB201312347D0 (en) Formulation
GB201317717D0 (en) Novel formulation
TWM476477U (en) Improved formulation for grain powder
GB201322181D0 (en) Feed formulation
GB201321280D0 (en) Feed formulation

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)